Telix Pharmaceuticals

Aktienkurs
9.85
Täglich Wechseln
-0.28 -2.76%
Monatlich
-10.54%
Jährlich
-65.99%
Q1 Prognose
9.65




Ebit Veränderung Datum
Cochlear AUD 275M 25.5M 2024-12
CSL USD 2.75B 1.35B 2024-12
Integral Diagnostics AUD 24.99M 5.08M 2024-06
Mayne Pharma AUD -16.2M 13.2M 2024-06
Medical Developments International AUD -12.12M 3.97M 2023-06
Mesoblast USD -42.11M 21.69M 2025-06
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Pacific Edge NZD -19.4M 2.91M 2025-12
Paradigm Biopharmaceuticals AUD -19.93M 12.02M 2023-06
Polynovo AUD 840K 147K 2024-06
PYC Therapeutics AUD -25.84M 3M 2024-12
Ramsay Health Care AUD 500.1M 14.8M 2024-12
ResMed USD 497.6M 35.25M 2025-12
Sonic Healthcare AUD 423.94M 80.3M 2024-12


Telix Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.